TTFactor's Business Development Advisory Board is composed of accomplished leaders from the healthcare industry and venture capital who bring their experience in science, medicine, business and finance to prioritize TTFactor's patent portfolio and foster its commercial exploitation. This team of experts has been created to serve scientists and ensure both Institutes that their intellectual properties are valued in accordance with fair principles, that means on the basis of their impact on patient’s care and their ability to become commercial products attractive for the industry.
Giulio DRAETTA, Director, MD Anderson Institute for Applied Cancer Science
Isaac KOHLBERG, Senior Associate Provost and Chief Technology Development Officer at Harvard University
Nagesh MAHANTAPPA, CEO & President at Scholar Rock LLC
Kazumi SHIOSAKI, Managing Partner at MPM Capital, Venture Capitalist
Katherine TURNER, Senior Vice President, Research at Scholar Rock LLC